Flash Finance

Jupiter Life Line Hospitals LimitedJLHLCorporate

Healthcare Latest results: Jun 2026 14 quarters of data
Consolidated Standalone
₹247.05
MCap ₹8,099 Cr · P/E 42.9
Jupiter Life Line Hospitals Limited — Stock analysis & AI research Jupiter Life Line Hospitals Limited — Multibagger AI analysis Jupiter Life Line Hospitals Limited — Seasonality — best & worst months Jupiter Life Line Hospitals Limited — Technical indicators & charts Jupiter Life Line Hospitals Limited — Technical setup — score, trend, support & resistance Jupiter Life Line Hospitals Limited — Falling Wedge pattern forming Jupiter Life Line Hospitals Limited — Live exchange announcements
📋 High Profit Growth Stocks 📈 Lowest Technical Score📈 Multi-Timeframe Bearish Stocks 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹328 Cr
Sales · Jun 2026
+18.2% YoY
₹69 Cr
Operating Profit · Jun 2026
+2.4% YoY
21.1%
OPM % · Jun 2026
-13.2% YoY
₹37 Cr
Net Profit · Jun 2026
-14.1% YoY
₹5.67
EPS · Jun 2026
-14.1% YoY

📝 Jupiter Life Line Hospitals Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Jupiter Life Line Hospitals Limited reported revenue of ₹328 crore for the quarter ended June 2026 (Q1 FY27), up 18.2% from ₹278 crore in the same quarter last year, and up 5.1% sequentially over the March 2026 quarter.

Net profit fell 14.1% year-on-year to ₹37 crore, from ₹43 crore. Earnings per share (EPS) came in at ₹5.67.

Operating profit stood at ₹69 crore — an operating margin (OPM) of 21.1%, compared with 24.3% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Jupiter Life Line Hospitals Limited posted revenue of ₹1,219 crore, a growth of 12.3% over FY25, with a net profit of ₹195 crore (up 3.4% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹1,269 crore with a net profit of ₹189 crore.

Valuation snapshot

At the current price of ₹247.05, JLHL has a market capitalisation of ₹8,099 crore and a trailing P/E of about 42.9.

Within the Healthcare industry, it is the 5th-largest of the 22 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 40.91%, foreign institutional investors (FIIs) 9.13%, domestic institutional investors (DIIs) 19.13%, public shareholders 30.83% of Jupiter Life Line Hospitals Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹8,099 Cr
Current Price ?
₹247.1
P/E ?
42.86above ind
Industry P/E ?
34.70
P/B ?
5.04
P/S ?
6.38
P/FCF ?
-32.14
Enterprise Value ?
₹8,434 Cr
EV/EBITDA ?
21.22
PEG ?
2.04
Earnings Yield ?
3.5%
Dividend Yield ?
0.08%
Profitability & Returns
Sales (TTM) ?
₹1,269 Cr
OPM ?
31.3%
Profit after tax (TTM) ?
₹189 Cr
EPS (TTM) ?
₹5.76
ROCE ?
16.0%
ROE ?
11.8%
ROA ?
8.7%
Growth
Sales — latest qtr ?
₹328 Cr
PAT — latest qtr ?
₹37 Cr
YoY qtr sales growth ?
18.2%
YoY qtr profit growth ?
-14.1%
Sales growth (3y) ?
15%
Sales growth (5y) ?
21%
Profit growth (3y) ?
21%
Profit growth (5y) ?
64%
Financial Health
Debt ?
₹335 Cr
Debt to Equity ?
0.21
Interest Coverage ?
12.7
Current Ratio ?
N/A
Ownership
Promoter holding ?
40.91%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
-20.5%
Return 6 months ?
-3.6%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 210208227230246239303269274278316312312328 +18.2% +5.1%
Operating Profit 52515957575678677268176747869 +2.4% -11.5%
Other Income 455810868713195911 -17.4% +19.0%
Interest 789111134316048 +170.4% +92.2%
Depreciation 7888781011131743161822 +29.4% +16.8%
Profit Before Tax 42414856595573626261136646650 -17.5% -23.5%
Net Profit 2730364243415449444355484937 -14.1% -24.4%
EPS 4.735.395.516.486.586.208.277.526.786.608.337.257.515.67 -14.1% -24.5%
OPM % 24.8% 24.5% 26.0% 24.8% 23.2% 23.3% 25.8% 25.1% 26.4% 24.3% 55.6% 23.8% 25.0% 21.1% -13.2% -15.6%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹1,085 Cr ₹1,219 Cr ₹1,269 Cr +12.3%
Operating Profit ₹273 Cr ₹396 Cr ₹397 Cr +44.8%
OPM % 25.19% 32.48% 31.31% +28.9%
NPM % 17.38% 16.00% 14.89% -7.9%
Other Income ₹29 Cr ₹46 Cr ₹44 Cr +58.4%
Depreciation ₹42 Cr ₹93 Cr ₹98 Cr +120.0%
Interest ₹8 Cr ₹24 Cr ₹29 Cr +191.3%
EBIT ₹231 Cr ₹302 Cr ₹299 Cr +31.0%
PBT ₹252 Cr ₹326 Cr ₹315 Cr +29.4%
Tax ₹63 Cr ₹50 Cr ₹45 Cr -21.1%
Net Profit ₹189 Cr ₹195 Cr ₹189 Cr +3.4%
EPS ₹28.77 ₹29.69 ₹28.76 +3.2%
Material Cost ₹203 Cr ₹179 Cr ₹187 Cr -11.7%
Employee Cost ₹194 Cr ₹153 Cr ₹162 Cr -21.4%
Extraordinary Items — ₹1 Cr ₹1 Cr —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 57666666 +0.0%
Reserves 4091,1801,3571,542 +13.6%
Borrowings 2980142335 +135.9%
Other Liabilities 123115145218 +50.3%
Total Liabilities 8851,3611,7102,160 +26.3%
Fixed Assets 4764777131,123 +57.5%
CWIP 1661163113 -30.7%
Investments 95111208580 +178.8%
Other Assets 297711626344 -45.0%
Total Assets 8851,3611,7102,160 +26.3%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 184110220231 +5.0%
Cash from Investing Activity -130-238-173-423 -144.5%
Cash from Financing Activity -23122302145 -52.0%
Net Cash Flow 31-6348-47 -113.5%
Free Cash Flow 14134-60-252 -320.0%
CFO/OP 107%70%105%97% -7.6%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 19181320 +53.8%
Inventory Days 42393549 +40.0%
Days Payable 169116157124 -21.0%
Cash Conversion Cycle -108-59-110-55 +50.0%
Working Capital Days -18-7-20136 +780.0%
ROCE % 27%22%18%16% -11.1%

👥 Shareholding (latest 6 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026 % Chg
Promoters 40.91%40.91%40.91%40.91%40.91%40.91% +0.0%
FIIs 9.77%9.06%8.48%8.48%9.37%9.13% -2.6%
DIIs 15.82%16.97%17.44%17.01%16.51%19.13% +15.9%
Public 33.51%33.08%33.17%33.60%33.21%30.83% -7.2%
No. of Shareholders 34,19234,36133,62032,98533,19433,255 +0.2%

⚖️ Peer comparison

Industry: Healthcare · 22 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 VIJAYA Vijaya Diagnostic ₹1,507.80 15,530 82.7 857 187 42.3% 21.8% 19.5% 20.2% 22.8% 37.3%
2 METROPOLIS Metropolis Healthcare ₹596.30 12,370 61.1 1,710 203 24.7% 11.9% 23.6% 31.4% 16.6% 25.7%
3 HCG Healthcare Global ₹704.05 10,512 390.9 2,626 33 18.2% 1.3% 14.6% -53.3% 13.1% 175.3%
4 YATHARTH Yatharth Hospital ₹988.90 9,528 54.1 1,200 171 23.6% 14.3% 36.2% 31.6% 47.6% 16.2%
5 JLHL Jupiter Life ₹277.85 9,109 9.7 1,557 187 22.1% 12.0% 20.9% -6.7% 18.2% -14.5%
6 THYROCARE Thyrocare Technologies ₹555.45 8,841 50.0 876 176 32.1% 20.1% 20.8% 79.4% 24.3% 33.2%
7 KOVAI Kovai Medical ₹6,260.50 6,850 26.7 1,644 256 27.9% 15.6% 15.7% 16.7% 15.3% 20.6%
8 INDRAMEDCO Indraprastha Medical ₹363.20 3,330 17.7 1,524 188 18.0% 12.4% 9.3% 13.7% 11.3% 9.5%
9 KRSNAA Krsnaa Diagnostics ₹543.40 1,763 18.1 816 98 26.8% 12.0% 7.8% 31.0% 22.1% -19.3%
10 SURAKSHA Suraksha Diagnostic ₹311.85 1,624 45.3 325 35 31.4% 10.8% 23.1% 1.4% 20.7% 40.0%
11 SHALBY Shalby ₹132.15 1,418 38.0 1,176 37 12.1% 3.2% 5.0% 1683.0% 11.7% 36.7%
12 GPTHEALTH GPT Healthcare ₹157.90 1,296 27.4 491 48 18.5% 9.8% 15.1% -21.9% 17.8% 62.5%
13 LAXMIDENTL Laxmi Dental ₹196.21 1,080 35.0 287 31 16.2% 10.9% 16.0% -10.1% 13.2% 28.9%
14 NEPHROCARE Nephro Care ₹234.80 387 — — — — — — — 68.4% 347.7%
15 LOTUSEYE Lotus Eye ₹114.50 243 n/m 57 0 8.5% 0.3% 8.4% -89.1% 26.2% 13.0%
16 UNIHEALTH Unihealth Hospitals ₹121.00 190 6.5 132 46 40.9% 34.8% — — 104.6% 71.5%
17 MADHAVBAUG Vaidya Sane ₹148.00 156 19.1 147 8 11.4% 5.6% — — 116.1% 94.3%
18 MHHL Mohini Health ₹57.05 104 — 145 -17 -1.4% -11.7% — — -6.6% -1400.0%
19 MAITREYA Maitreya Medicare ₹120.65 82 — 45 -2 -1.0% -5.5% — — -5.2% -1720.0%
20 AATMAJ Aatmaj Healthcare ₹26.75 60 83.6 24 1 9.7% 2.9% — — 22.5% -39.4%
21 NIDAN Nidan Laborator. ₹33.00 46 30.6 26 2 19.0% 5.9% — — -11.2% -92.0%
22 ARTEMISMED Artemis Medicare ₹315.00 — 48.0 1,081 103 17.4% 9.6% 15.4% 25.9% 16.3% 30.9%
❓ Frequently asked questions
What was Jupiter Life Line Hospitals Limited's revenue in Q1 FY27?
Jupiter Life Line Hospitals Limited reported revenue of ₹328 crore for the quarter ended June 2026 (Q1 FY27), up 18.2% from ₹278 crore in the same quarter last year, and up 5.1% sequentially over the March 2026 quarter.
What was Jupiter Life Line Hospitals Limited's net profit in Q1 FY27?
Net profit fell 14.1% year-on-year to ₹37 crore, from ₹43 crore. Earnings per share (EPS) came in at ₹5.67.
What is JLHL's market capitalisation and P/E ratio?
At the current price of ₹247.05, JLHL has a market capitalisation of ₹8,099 crore and a trailing P/E of about 42.9.
Who owns Jupiter Life Line Hospitals Limited? (shareholding pattern)
As of Sep 2026, promoters held 40.91%, foreign institutional investors (FIIs) 9.13%, domestic institutional investors (DIIs) 19.13%, public shareholders 30.83% of Jupiter Life Line Hospitals Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI